Artritis idiopática juvenil

1. Espinosa M, Gottlieb BS. Juvenile idiopathic arthritis. Pediatr Rev. 2012;33(7):303–313

2. Nigrovic PA, Colbert RA, Holers VM, et al. Biological classification of childhood arthritis: roadmap to a molecular nomenclature. Nat Rev Rheumatol. 2021;17(5):257–269

3. Martini A, Ravelli A, Avcin T, et al; Pediatric Rheumatology International Trials Organization (PRINTO). Toward new classification criteria for juvenile idiopathic arthritis: First Steps, Pediatric Rheumatology International Trials Organization International Consensus. J Rheumatol. 2019;46(2):190–197

4. Angeles-Han ST, Ringold S, Beukelman T, et al. 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Screening, Monitoring, and Treatment of Juvenile Idiopathic Arthritis-Associated Uveitis. Arthritis Rheumatol. 2019;71(6):864–877

5. Gowdie PJ, Tse SM. Juvenile idiopathic arthritis. Pediatr Clin North Am. 2012;59(2):301–327

6. Glerup M, Herlin T, Twilt M. Clinical outcome and long-term remission in JIA. Curr Rheumatol Rep. 2017;19(12):75

7. Ter Haar NM, van Dijkhuizen EHP, Swart JF, et al. Treatment to target using recombinant interleukin-1 receptor antagonist as first-line monotherapy in new-onset systemic juvenile idiopathic arthritis: results from a five-year follow-up study. Arthritis Rheumatol. 2019;71(7):1163–1173

8. Mistry RR, Patro P, Agarwal V, Misra DP. Enthesitis-related arthritis: current perspectives. Open Access Rheumatol. 2019; 11:19–31

9. Girolimetto N, Giovannini I, Crepaldi G, et al. Psoriatic dactylitis: current perspectives and new insights in ultrasonography and magnetic resonance imaging. J Clin Med. 2021;10(12):2604

10. Giancane G, Alongi A, Ravelli A. Update on the pathogenesis and treatment of juvenile idiopathic arthritis. Curr Opin Rheumatol. 2017;29(5):523–529

11. Zaripova LN, Midgley A, Christmas SE, Beresford MW, Baildam EM, Oldershaw RA. Juvenile idiopathic arthritis: from aetiopathogenesis to therapeutic approaches. Pediatr Rheumatol Online J. 2021;19(1):135

12. Marasco E, Aquilani A, Cascioli S, et al. Switched memory B cells are increased in oligoarticular and polyarticular juvenile idiopathic arthritis and their change over time is related to response to tumor necrosis factor inhibitors. Arthritis Rheumatol. 2018;70(4):606–615

13. Arve-Butler S, Schmidt T, Mossberg A, et al. Synovial fluid neutrophils in oligoarticular juvenile idiopathic arthritis have an altered phenotype and impaired effector functions. Arthritis Res Ther. 2021;23(1):109

14. Fotis L, Shaikh N, Baszis KW, et al. Serologic evidence of gut-driven systemic inflammation in juvenile idiopathic arthritis. J Rheumatol. 2017;44(11):1624–1631

15. Frid P, Nordal E, Bovis F, et al; Paediatric Rheumatology International Trials Organisation. Temporomandibular joint involvement in association with quality of life, disability, and high disease activity in juvenile idiopathic arthritis. Arthritis Care Res (Hoboken). 2017;69(5):677–686

16. von Kalle T, Stuber T, Winkler P, Maier J, Hospach T. Early detection of temporomandibular joint arthritis in children with juvenile idiopathic arthritis: the role of contrast-enhanced MRI. Pediatr Radiol. 2015;45(3):402–410

17. Bracaglia C, de Graaf K, Pires Marafon D, et al. Elevated circulating levels of interferon-γ and interferon-γ-induced chemokines characterise patients with macrophage activation syndrome complicating systemic juvenile idiopathic arthritis. Ann Rheum Dis. 2017;76(1):166–172

18. Binstadt BA, Nigrovic PA. The conundrum of lung disease and drug hypersensitivity-like reactions in systemic juvenile idiopathic arthritis. Arthritis Rheumatol. 2022;74(7):1122–1131